Tuesday 18 September 2012

Fleming Europe Discussing New PPM Strategies In Frankfurt, 15-16 November 2012

Due to high uncertainty of success and destinations of substantial investments, pharmaceutical development projects tend to be many years in duration. According to this situation and existing challenges such as the effective management of drug development portfolios, the impact of rising R&D costs and falling productivity levels, pharma companies have started paying greater attention to their portfolio strategies, resource allocation and decision making processes... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment